- Description
- Curriculum
- Reviews
- Grade
Certified Travel Medicine Practitioner of Nigeria (CTMPN)
by: Nigerian Society of Travel Medicine (NSTM)
Course Overview
Duration: 13 weeks
Modules: 13 (video + PDF content + quizzes)
Final Project: Capstone (case study or simulation video)
Registration is ongoing for the Travel Medicine Certification course.
Join this cohort and learn from seasoned experts in travel medicine.
Course Fee: 100,000 Naira
Course Fee + Membership: 150,000 Naira (This includes membership into the Nigerian Society of Travel Medicine and the Pan African Travel Medicine Federation for a year).
Enrol now and book your slot.
Commencement Date: 2nd March 2026
Visit: https://nstm.org.ng/ctmpn
#TravelMedicine #CertificationCourse
Contact: info@nstm.org.ng
-
1Welcome Address for the First Nigerian Owned Travel Medicine Certification Course
-
2Time Table
Dear Participants,
Please find below the timetable for the course.
Kindly note that progression to the next module is contingent upon the completion of the preceding module’s assessment questions and the approval of the submitted reflective write-ups. The deadline for the completion of each module is as indicated on a weekly basis.
Please also be advised that different assessors are assigned to different participants; therefore, notifications regarding weekly assignments may vary. However, please be assured that all notifications will be issued within the week indicated on the timetable.
The timetable will be strictly adhered to.
We wish you every success in your studies.
Warm regards,
The Academic Team -
3Welcome message from the Chairman, Board of Trustees, The Nigerian Society for Travel Medicine - Dr. Patrick Olisa Chukwumah
-
4Meet Your Facilitators
-
5Course Objectives
By the end of this course, participants will be able to:
- Understand the Scope and Importance of Travel Medicine
- Recognize Travel-Related Health Risks
- Conduct Comprehensive Pre-Travel Consultations
- Advise on Vaccination and Preventive Measures
- Promote Safe Travel Practices
- Guide In-Travel and Post-Travel Health Management
- Apply Ethical and Culturally Sensitive Communication
- Utilize Case-Based Reasoning in Clinical Scenarios
-
6Definitions and Scope of Travel Medicine
-
7Epidemiology of Travel-Related Illnesses
-
8Principles of Travel Health
-
9Role of Travel Medicine Practitioners
-
10Regulatory Framework and International Health Regulations for Travel Medicine in Nigeria
This lecture will examine the key components of the regulatory landscape for travel medicine in Nigeria, including the roles of various health authorities and the implications for travelers and healthcare providers.
-
11Assessment
-
12Reflective Write Up
-
19Module 3. Infectious Diseases and Travel-Related Illnesses.
-
20Assessment
-
21Reflective Write Up
-
22Further reading on Malaria
Malaria and Travel Risk
Malaria remains a major cause of morbidity and mortality in travelers to endemic regions, especially sub-Saharan Africa, Southeast Asia, and parts of South America. The choice of antimalarial chemoprophylaxis depends on:
• Geographic resistance patterns
• Length of stay
• Traveler's health status
• Drug tolerability and cost
Key Antimalarial Agents
Drug
Regimen
Notes
Atovaquone-Proguanil
(Malarone)
Daily; start 1–2 days before travel, continue 7 days after
Well tolerated; not for pregnancy
Doxycycline
Daily; start 1–2 days before, continue 4 weeks after
GI upset, sun sensitivity
Mefloquine
Weekly; start 2 weeks before, continue 4 weeks after
Neuropsych side effects; not for history of seizures
Chloroquine
Weekly; use only where resistance is low
Retinal toxicity risk
Primaquine
Daily; for P. vivax/ovale prevention
Requires G6PD test
Prescribing Tips
• Always personalize prophylaxis based on the traveler's profile.
• Explain the importance of adherence, especially post-travel.
• Provide written instructions on missed doses, side effects, and what to do in case of febrile illness.
For further reading, click on this link
https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/malaria.html
-
23Introduction
This module provides an in-depth overview of the most relevant medications in travel medicine, best practices in travel prescribing, and legal and ethical considerations around traveling with controlled substances.
-
24Drug Prescription and Counsel while Travelling
-
25Legal Pitfalls for narcotics and Psychotropics
-
26Medication concerns at Airports and other Cross country borders
-
27Assessment
-
28Reflective Write Up
-
29Further Reading
Yakkan Shoumei" (薬監証明) is a Japanese import certificate required for bringing certain medications into Japan for personal use, particularly when the quantity exceeds a specified limit or when dealing with controlled substances. It's essentially a pre-approval process to ensure compliance with Japanese regulations regarding medication importation
-
36Introduction
-
37Techniques for effective risk communication in Travel medicine
-
38Educational Strategies for Travel Medicine Practitioners
-
39Cultural and Ethical Considerations in Travel Health Education and Counselling
-
40Case Study: The Hajj Pilgrim with "Brittle" Diabetes
-
41Assessment
-
42Reflective Write Up
-
50Introduction
Learning Objectives
By the end of this session, you will be equipped to:
- Deconstruct Core Ethical Principles: Evaluate the application of beneficence, non-maleficence, and distributive justice within the specific context of international population mobility.
- Execute Professional Standards: Apply rigorous conduct standards to complex, real-world scenarios, ensuring that clinical advice remains objective and evidence-based.
- Navigate Specialty-Specific Dilemmas: Recognize and resolve ethical conflicts unique to travel medicine, such as the tension between mandatory reporting and patient confidentiality.
Synthesize Legal and Global Best Practices: Uphold patient autonomy and data privacy in strict alignment with the Nigerian National Health Act, the NDPR, and WHO International Health Regulations
-
51Common Ethical Challenges in Nigerian Travel Medicine Practice
-
52Professional Conduct Standards
-
53Ethical Principles in Travel Medicine
-
54Assessment
-
55Reflective Write Up
-
56Introduction
-
57Key Preparation Steps for Patient's Medical Evacuation
-
58Nigeria’s Policy on Medical Tourism and Legal and Ethical Framework
-
59Transport Considerations: Ground vs. Air Ambulance
-
60The Medevac Clinical Handover (SBAR)
In the high-acuity transition from a ground facility to a flight team, the SBAR (Situation, Background, Assessment, Recommendation) framework is the international gold standard. It strips away the noise and ensures that the flight physician or nurse receives a clinical "snapshot" that is actionable at 30,000 feet.
Medevac Clinical Handover (SBAR)
S: Situation
· Patient Name/Age/Sex: "We are transferring Mr [Name], 64 years old."
· Primary Diagnosis: "Acute Myocardial Infarction with cardiogenic shock."
· Current Status: "Patient is currently intubated, sedated, and stabilized on dual vasopressors. We are transferring for urgent percutaneous coronary intervention (PCI)."
B: Background
· Admission Timeline: "Admitted 6 hours ago following sudden onset chest pain."
· Critical Interventions: "Thrombolysed at 0800hrs with partial resolution of ST-segment elevation. Intubated at 1000hrs due to respiratory failure."
· Comorbidities: "Known Type 2 Diabetic and hypertensive. No known drug allergies."
· Access/Lines: "Right internal jugular central line and left radial arterial line are in situ."
A: Assessment
· Vitals: "Last BP 95/60 (on Norepinephrine), HR 110 (Sinus Tach), SpO2 96% on FiO2 60%."
· Recent Changes: "Urine output has been declining over the last 2 hours (<0.5ml/kg/hr)."
· Concerns: "The patient is extremely sensitive to movement; we observed a BP drop of 20mmHg during the last repositioning."
R: Recommendation
· Transport Goals: "Maintain MAP > 65mmHg. Keep sedation deep to prevent 'fighting' the ventilator during ascent."
· Contingencies: "If BP drops further, increase Norepinephrine by [X] increments. We have provided 2 extra bags of pressors and 1 unit of packed red cells for the flight."
· Receiving Contact: "Dr. [Name] at [Hospital] is expecting the patient. The direct line is in the packet."
The "Golden Minute" of Handover
When the flight team arrives, the physical handover should be a choreographed event.
1. Stop and Listen: Once the SBAR is delivered, give the transport team one minute to ask clarifying questions before moving the patient.
2. Monitor Swap: Always overlap monitoring. Do not disconnect the patient from your bedside monitor until they are fully visualized on the transport monitor.
3. The "Paper" Handover: Physically hand over the Clinical Passport (the USB/CD of imaging, the medication log, and the signed consent forms).
-
61Medical Evacuation Checklist
-
62Required Skills and Qualifications for Practitioners
-
63Post-Evacuation Repatriation.
-
64Conclusion
-
65Assessment
-
66Reflective Write Up
-
67Overview
-
68The Rise of Virtual Clinics in Travel Medicine
-
69Application of "Virtual Clinic" in Travel Medicine
-
70Checklist for Running a Virtual Travel Medicine Clinic
-
71Limitations of Telemedicine in Travel Medicine and the Telemedicine Escalation Protocol
-
72Data Protection in Virtual Travel Clinics
-
73Assessment Telemedicine
-
74Reflective Write Up
-
75Overview of Maritime and Aviation Health
In aviation and maritime medicine, the Standard of Care is defined by the environment. You cannot apply "land-based" clinical assumptions to a patient who is three weeks away from the nearest surgical theater or a pilot navigating a transcontinental flight. This module will equip you with the specialized "Environmental Intelligence" required to manage health in these isolated, high-stakes corridors of global mobility.
-
76Principles of Aviation Medicine  and Clinical Risk Management for the General Traveler.
-
77Principles of Maritime Medicine
-
78Comparative Environmental Physiology
-
79Assessment
-
80Reflective Write Up
-
81Further Reading on Scuba Diving , Decompression Sickness, Pulmonary Embolism and DVT in Travellers